Media Center

GlobalData Healthcare Press Releases

As the premier provider of research and consulting for the healthcare market, GlobalData can provide timely commentary for journalists wishing to gain industry perspective and valuable insight for their articles.

View our press releases to learn more about our latest research and analysis on the healthcare industry.

Press ReleasesRSS Feed

  1. Diabetic foot ulcer market to surpass $870 million by 2025, despite a harsh market environment, says GlobalData

    The combined diabetic foot ulcer (DFU) and diabetic foot infection (DFI) market is set to triple in value from $292.1 million in 2015 to $873.4 million by 2025, representing a compound annual growth rate of 11.6%, according to research and consulting firm GlobalData.

  2. Despite uncertainty surrounding future healthcare policy, the US pharmaceutical market will approach $500 billion by 2020, says GlobalData

    The US pharmaceutical market is expected to increase from $354 billion in 2015 to $497 billion by 2020, representing a compound annual growth rate of 4.4%, according to research and consulting firm GlobalData.

  3. Spinal fusion market to approach $9 billion by 2023 as technology improves, says GlobalData

    The global market for spinal fusion, which includes spinal plating systems, interbody devices, vertebral body replacement devices, and pedicle screw systems (excluding minimally invasive spine devices), is set to rise from approximately $7.1 billion in 2016 to just under $9 billion by 2023, representing a compound annual growth rate of 3.4%, according to research and consulting firm GlobalData.

  4. Oncology companion diagnostics market will approach $414 million by 2023, says GlobalData

    The global oncology companion diagnostic testing market across the 10 major countries of the US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil is set to rise from $260 million in 2016 to just under $414 million by 2023, representing a compound annual growth rate (CAGR) of 6.9%, according to research and consulting firm GlobalData.

  5. Etelcalcetide set to become blockbuster in hyperparathyroidism market by 2025, says GlobalData

    The hyperparathyroidism therapeutics market is set to rise from $6.69 billion in 2015 to $8.04 billion by 2025, representing a compound annual growth rate of 1.8%, according to research and consulting firm GlobalData.

© GlobalData 2017. John Carpenter House, 7 Carmelite Street, London EC4 0BS.